Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Jiranek

Orthopaedic Surgery Durham, NC Medical Doctor

NPI 1184714941 CMS profile 235778

4709 Creekstone Dr, Suite 300, Durham, NC 27703

Open in the dashboard

General payments

$6,393,097

121 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Jiranek of Durham, NC is reported in the CMS Open Payments database as having received $6,393,097 across 121 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $675,196 12
2024 General $633,193 11
2023 General $742,025 19
2022 General $800,411 18
2021 General $1,185,000 19
2020 General $1,074,041 19
2019 General $1,283,231 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Jiranek
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Jiranek were reported at $675,196. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year William Jiranek Orthopaedic Surgery median Middle half National median
2019 $1,283,231 $644 $140–$2,844 $163
2020 $1,074,041 $312 $75–$1,860 $114
2021 $1,185,000 $520 $117–$2,495 $132
2022 $800,411 $598 $128–$2,731 $149
2023 $742,025 $461 $128–$2,264 $160
2024 $633,193 $497 $134–$2,475 $164
2025 $675,196 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Products, Inc. $6,359,863 53 payments
  2. Medical Device Business Services, Inc. $15,693 13 payments
  3. MicroPort Orthopedics Inc $8,317 9 payments
  4. Synthes GmbH $6,089 10 payments
  5. Smith+Nephew, Inc. $1,057 12 payments
  6. Zimmer Biomet Holdings, Inc. $695 10 payments
  7. Total Joint Orthopedics, Inc. $483 4 payments
  8. LinkBio Corp $185 2 payments
  9. Moximed, Inc $167 2 payments
  10. Davol Inc. $148 1 payment
  11. Other $399 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $6,354,075 48 payments
  2. Consulting Fee $29,200 10 payments
  3. Travel and Lodging $4,902 17 payments
  4. Food and Beverage $3,420 45 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $1,500 1 payment
Products named General payments · program years 2019–2025
  1. ATTUNE Ortho-Knee $3,506,628 30 payments
  2. ATTUNE Ortho-Knee $1,282,177 16 payments
  3. SIGMA Ortho-Knee $1,066,253 9 payments
  4. SUMMIT Ortho-Hip $1,066,253 9 payments
  5. SIGMA Ortho-Knee $519,697 5 payments
  6. SUMMIT Ortho-Hip $519,697 5 payments
  7. MPO Hip System $8,239 8 payments
  8. ROSA $597 7 payments
  9. JOURNEY II UK $416 6 payments
  10. POLARSTEM $348 1 payment
  11. Other $3,031 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

35

Median for Orthopedic Surgery: 203

Drug cost

$50

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 35 $50

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$119,086

Medicare's payments for the services billed

Medicare patients

300

Average age 73

Services billed

1,199

175 women, 125 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Depression 27%
Diabetes 25%
Ischemic heart disease 25%
Osteoporosis 21%
Chronic kidney disease 20%
Atrial fibrillation 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

121 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record